Scotia Capital’s ViewRay, Inc. VRAY Stock Holding History

Scotia Capital’s Portfolio VRAY Stock Details VRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$29K	–	785
2019 Q3	$29K	Buy	+10,000	New	+$59.2K	﹤0.01%	710

Other funds holding VRAY

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PCM

Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Scotia Capital's VRAY Position: Q4 2019 in Review

Scotia Capital sold out of ViewRay, Inc. (VRAY) in Q4 2019, closing a stake of 10,000 shares — an estimated $29K sold.

Scotia Capital first reported a position in VRAY in Q3 2019 and held it in 1 quarter. The position peaked at $29K in Q3 2019. 135 funds tracked by Wall St. Rank hold VRAY as of Q4 2019.

Scotia Capital reported no remaining ViewRay, Inc. position as of Q4 2019 after selling out during the quarter.
Scotia Capital sold 10,000 ViewRay, Inc. shares in Q4 2019, an estimated $29K.
Scotia Capital first reported a position in ViewRay, Inc. in Q3 2019 and held it in 1 quarter.
Scotia Capital's ViewRay, Inc. position peaked at $29K in Q3 2019.
135 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q4 2019.

Based on Scotia Capital's 13F filing for Q4 2019, filed 13 Feb 2020.